149 related articles for article (PubMed ID: 34388159)
1. Psychometric characteristics of DLQI-BRA and Skindex-16 to measure the impact of dermatological diseases on quality of life in Brazilian patients.
Meneguin S; de Souza Matos TD; Pollo CF; Garuzi M; Miot HA; de Oliveira C
PLoS One; 2021; 16(8):e0254882. PubMed ID: 34388159
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Skindex-17 quality of life assessment instrument for a Brazilian population.
Jorge MFS; Mourão IB; Pollo CF; Sousa TD; Meneguin S; Miot HA
An Bras Dermatol; 2021; 96(1):51-58. PubMed ID: 33281012
[TBL] [Abstract][Full Text] [Related]
3. The Brazilian version of Skindex-16 is a valid and reliable instrument to assess the health-related quality of life of patients with skin diseases.
Cárcano CBM; de Oliveira CZ; Paiva BSR; Paiva CE
PLoS One; 2018; 13(3):e0194492. PubMed ID: 29566036
[TBL] [Abstract][Full Text] [Related]
4. Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16.
He Z; Lu C; Chren MM; Zhang Z; Li Y; Ni X; Buchtel V HA; Ryan PF; Li GZ
Health Qual Life Outcomes; 2014 Dec; 12():190. PubMed ID: 25539748
[TBL] [Abstract][Full Text] [Related]
5. Dimensionality and psychometric analysis of DLQI in a Brazilian population.
Jorge MFS; Sousa TD; Pollo CF; Paiva BSR; Ianhez M; Boza JC; Meneguin S; Schmitt JV; Nunes DH; Lastoria JC; Miot HA
Health Qual Life Outcomes; 2020 Aug; 18(1):268. PubMed ID: 32758227
[TBL] [Abstract][Full Text] [Related]
6. Translation and Validation of the Serbian Version of the Skindex-29 Instrument for Measuring Impact of Skin Disease on Quality of Life.
Milutinović JD; Krstić N; Janković SM
Acta Dermatovenerol Croat; 2017 Jul; 25(2):120-127. PubMed ID: 28871926
[TBL] [Abstract][Full Text] [Related]
7. Comparison of generic and specific instruments to assess the quality of life in patients with melasma.
Meneguin S; Mourão IB; Pollo CF; Miot HA; Garuzi M; de Oliveira C
BMC Med Res Methodol; 2022 Apr; 22(1):117. PubMed ID: 35443616
[TBL] [Abstract][Full Text] [Related]
8. Conceptualization, development and validation of T-QoL
Basra MKA; Salek MS; Fenech D; Finlay AY
Br J Dermatol; 2018 Jan; 178(1):161-175. PubMed ID: 28762236
[TBL] [Abstract][Full Text] [Related]
9. Translation, cultural adaptation, and validation of the American Skindex-29 quality of life index.
Paula HR; Haddad A; Weiss MA; Dini GM; Ferreira LM
An Bras Dermatol; 2014; 89(4):600-7. PubMed ID: 25054747
[TBL] [Abstract][Full Text] [Related]
10. A comparative study on the measurement properties of Dermatology Life Quality Index (DLQI), DLQI-Relevant and Skindex-16.
Szabó Á; Brodszky V; Rencz F
Br J Dermatol; 2022 Mar; 186(3):485-495. PubMed ID: 34724199
[TBL] [Abstract][Full Text] [Related]
11. Pictorial Representation of Illness and Self Measure (PRISM): A novel visual instrument to measure quality of life in dermatological inpatients.
Mühleisen B; Büchi S; Schmidhauser S; Jenewein J; French LE; Hofbauer GF
Arch Dermatol; 2009 Jul; 145(7):774-80. PubMed ID: 19620558
[TBL] [Abstract][Full Text] [Related]
12. [Assessment on the reliability and validity of the Dermatology Life Quality Index in Chinese version].
Wang XL; Zhao TE; Zhang XQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):791-3. PubMed ID: 15555362
[TBL] [Abstract][Full Text] [Related]
13. Field performance of the Skindex-17 quality of life questionnaire: a comparison with the Skindex-29 in a large sample of dermatological outpatients.
Sampogna F; Spagnoli A; Di Pietro C; Pagliarello C; Paradisi A; Tabolli S; Abeni D
J Invest Dermatol; 2013 Jan; 133(1):104-9. PubMed ID: 22832497
[TBL] [Abstract][Full Text] [Related]
14. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis.
Mazzotti E; Barbaranelli C; Picardi A; Abeni D; Pasquini P
Acta Derm Venereol; 2005; 85(5):409-13. PubMed ID: 16159732
[TBL] [Abstract][Full Text] [Related]
15. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease.
Basra MK; Sue-Ho R; Finlay AY
Br J Dermatol; 2007 Mar; 156(3):528-38. PubMed ID: 17300244
[TBL] [Abstract][Full Text] [Related]
16. A method to select an instrument for measurement of HR-QOL for cross-cultural adaptation applied to dermatology.
de Tiedra AG; Mercadal J; Badía X; Mascaró JM; Lozano R
Pharmacoeconomics; 1998 Oct; 14(4):405-22. PubMed ID: 10344908
[TBL] [Abstract][Full Text] [Related]
17. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases.
Higaki Y; Kawamoto K; Kamo T; Horikawa N; Kawashima M; Chren MM
J Dermatol; 2002 Nov; 29(11):693-8. PubMed ID: 12484430
[TBL] [Abstract][Full Text] [Related]
18. Cross validation of the Turkish version of dermatology life quality index.
Oztürkcan S; Ermertcan AT; Eser E; Sahin MT
Int J Dermatol; 2006 Nov; 45(11):1300-7. PubMed ID: 17076710
[TBL] [Abstract][Full Text] [Related]
19. Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument.
Gupta V; Sreenivas V; Mehta M; Khaitan BK; Ramam M
Br J Dermatol; 2014 Nov; 171(5):1084-90. PubMed ID: 24805089
[TBL] [Abstract][Full Text] [Related]
20. Clinical meaning in skin-specific quality of life instruments: a comparison of the Dermatology Life Quality Index and Skindex banding systems.
Rogers A; DeLong LK; Chen SC
Dermatol Clin; 2012 Apr; 30(2):333-42, x. PubMed ID: 22284147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
